nodes	percent_of_prediction	percent_of_DWPC	metapath
Enoxacin—TOP2A—Epirubicin—bone cancer	0.602	0.653	CbGbCtD
Enoxacin—TOP2A—Doxorubicin—bone cancer	0.32	0.347	CbGbCtD
Enoxacin—TOP2A—Gastric Cancer Network 1—C21orf33—bone cancer	0.0137	0.2	CbGpPWpGaD
Enoxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—T—bone cancer	0.0079	0.116	CbGpPWpGaD
Enoxacin—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.00603	0.0883	CbGpPWpGaD
Enoxacin—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.00221	0.0324	CbGpPWpGaD
Enoxacin—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00198	0.029	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—TNFRSF11A—bone cancer	0.00187	0.0274	CbGpPWpGaD
Enoxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—bone cancer	0.00154	0.0225	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—DHFR—bone cancer	0.00132	0.0194	CbGpPWpGaD
Enoxacin—TOP2A—Idarubicin—Epirubicin—bone cancer	0.00132	0.173	CbGdCrCtD
Enoxacin—TOP2A—Daunorubicin—Epirubicin—bone cancer	0.00132	0.173	CbGdCrCtD
Enoxacin—TOP2A—Doxorubicin—Epirubicin—bone cancer	0.00132	0.173	CbGdCrCtD
Enoxacin—TOP2A—Epirubicin—Doxorubicin—bone cancer	0.00123	0.16	CbGdCrCtD
Enoxacin—TOP2A—Idarubicin—Doxorubicin—bone cancer	0.00123	0.16	CbGdCrCtD
Enoxacin—TOP2A—Daunorubicin—Doxorubicin—bone cancer	0.00123	0.16	CbGdCrCtD
Enoxacin—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.00114	0.0167	CbGpPWpGaD
Enoxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00107	0.0157	CbGpPWpGaD
Enoxacin—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.00104	0.0152	CbGpPWpGaD
Enoxacin—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000996	0.0146	CbGpPWpGaD
Enoxacin—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000956	0.014	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—DHFR—bone cancer	0.000932	0.0136	CbGpPWpGaD
Enoxacin—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.00092	0.0135	CbGpPWpGaD
Enoxacin—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000853	0.0125	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000848	0.0124	CbGpPWpGaD
Enoxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—bone cancer	0.000844	0.0124	CbGpPWpGaD
Enoxacin—TOP2A—Gastric Cancer Network 2—EGFR—bone cancer	0.000805	0.0118	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—ZW10—bone cancer	0.000802	0.0117	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000721	0.0106	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—ZW10—bone cancer	0.000717	0.0105	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.000696	0.0102	CbGpPWpGaD
Enoxacin—TOP2A—Gastric Cancer Network 2—TP53—bone cancer	0.000676	0.00989	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000657	0.00962	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—GNA11—bone cancer	0.000633	0.00927	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—EZH2—bone cancer	0.000631	0.00923	CbGpPWpGaD
Enoxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000625	0.00916	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.000608	0.0089	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.000605	0.00886	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000598	0.00876	CbGpPWpGaD
Enoxacin—Levofloxacin—CYP3A4—bone cancer	0.000593	0.36	CrCbGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.00059	0.00864	CbGpPWpGaD
Enoxacin—Ciprofloxacin—CYP3A4—bone cancer	0.000573	0.348	CrCbGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—RFC1—bone cancer	0.000551	0.00807	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—TUBB4B—bone cancer	0.000544	0.00796	CbGpPWpGaD
Enoxacin—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000539	0.00789	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.000516	0.00755	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.0005	0.00732	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—RFC1—bone cancer	0.000493	0.00722	CbGpPWpGaD
Enoxacin—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000491	0.00719	CbGpPWpGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—bone cancer	0.000489	0.00717	CbGpPWpGaD
Enoxacin—Norfloxacin—CYP3A4—bone cancer	0.000481	0.292	CrCbGaD
Enoxacin—TOP2A—Mitotic G1-G1/S phases—RB1—bone cancer	0.000426	0.00623	CbGpPWpGaD
Enoxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000397	0.00581	CbGpPWpGaD
Enoxacin—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000392	0.00574	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000371	0.00543	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—CDK4—bone cancer	0.000356	0.00521	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—DHFR—bone cancer	0.000342	0.005	CbGpPWpGaD
Enoxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000322	0.00471	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—DHFR—bone cancer	0.000306	0.00447	CbGpPWpGaD
Enoxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—bone cancer	0.000296	0.00433	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000275	0.00402	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000265	0.00388	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000265	0.00388	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—CHEK2—bone cancer	0.000255	0.00374	CbGpPWpGaD
Enoxacin—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.00025	0.00366	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000239	0.0035	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—JUN—bone cancer	0.000229	0.00336	CbGpPWpGaD
Enoxacin—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.000226	0.0033	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000218	0.00319	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—BRCA2—bone cancer	0.000216	0.00317	CbGpPWpGaD
Enoxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	0.000204	0.00298	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000196	0.00287	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000188	0.00275	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—CDK4—bone cancer	0.00018	0.00263	CbGpPWpGaD
Enoxacin—CYP1A2—Biological oxidations—CYP3A4—bone cancer	0.000171	0.0025	CbGpPWpGaD
Enoxacin—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	0.000169	0.00247	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—CDK4—bone cancer	0.000161	0.00235	CbGpPWpGaD
Enoxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000158	0.00231	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle, Mitotic—RB1—bone cancer	0.000156	0.00229	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000154	0.00226	CbGpPWpGaD
Enoxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000154	0.00226	CbGpPWpGaD
Enoxacin—TOP2A—Circadian rythm related genes—TP53—bone cancer	0.000151	0.00222	CbGpPWpGaD
Enoxacin—CYP1A2—Biological oxidations—GSTP1—bone cancer	0.000146	0.00214	CbGpPWpGaD
Enoxacin—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	0.000144	0.00211	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—RB1—bone cancer	0.00014	0.00204	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—MDM2—bone cancer	0.000119	0.00174	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—NDUFA12—bone cancer	0.000102	0.0015	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—NT5C3A—bone cancer	8.49e-05	0.00124	CbGpPWpGaD
Enoxacin—TOP2A—Cell Cycle—TP53—bone cancer	6.83e-05	0.001	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—ENO2—bone cancer	3.72e-05	0.000545	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—DHFR—bone cancer	3.45e-05	0.000505	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—GNA11—bone cancer	3.23e-05	0.000472	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—CYP3A4—bone cancer	2.92e-05	0.000428	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.91e-05	0.000426	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—GSTP1—bone cancer	2.5e-05	0.000366	CbGpPWpGaD
Enoxacin—CYP1A2—Metabolism—PTGS2—bone cancer	1.3e-05	0.00019	CbGpPWpGaD
